reviewNature Reviews Drug DiscoveryJul 1, 2003Closed access

Clinical biomarkers in drug discovery and development

Verizon (United States) · Merck & Co., Inc., Rahway, NJ, USA (United States) · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

789
total citations
FWCI
54.96
Percentile
100%
References
171
Citations per year

Authors

2

Topics & keywords

Keywords
  • Biomarker discovery
  • Drug development
  • Drug discovery
  • Drug
  • Medicine
  • Biomarker
  • Disease
  • Computational biology
No related works found for this paper.